Revlimid vs Xarelto
Side-by-side drug price comparison from Medicare Part D data
Verdict
Xarelto costs 97% less per claim than Revlimid ($321.00 vs $12786.00). Xarelto has a generic alternative available. Total Medicare spending: Revlimid at $7.8B vs Xarelto at $5.0B.
| Metric | Revlimid | Xarelto |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $12,786 | $321* |
| Total Medicare Spending Total Medicare Part D spending on this drug | $7.8B | $5.0B |
| Total Claims | 612,000 | 15,680,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | -3.4%* | -1.2% |
| Generic Available | No | Yes |
| Condition | Cancer | Blood Clots |
| Total Beneficiaries | 58,000 | 1,920,000 |
Xarelto costs 97% less per claim than Revlimid ($321.00 vs $12786.00). Xarelto has a generic alternative available. Total Medicare spending: Revlimid at $7.8B vs Xarelto at $5.0B.